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Abstract 
A MTT/formazan assay was used to evaluate the an-
titumor activity of vitamin C (Vit C), vitamin K3 
(Vit K3), or vitamin C:vitamin K3 combinations against 
a human prostatic carcinoma cell line (DU145). Both 
Vit C and Vit K3 alone exhibited antitumor activity, but 
only at elevated doses. When Vit C and Vit K3 were 
combined at a C:K3 ratio of 100: 1 and administered to 
the carcinoma cells, the 50 % cytotoxic concentrations 
(CD50) of the vitamins decreased 10- to 60-fold. Subse-
quently, the DU145 cells were examined with transmis-
sion and scanning electron microscopy (TEM and SEM) 
following a 1 hour treatment with Vit C, Vit K3, or 
Vit C/K3 combined at their 50% cytotoxic dose. Our 
morphological data suggest that vitamin treatment with 
individual vitamins affects the cytoskeleton, the mito-
chondria, and other membranous components of the cell. 
Treatment with the vitamin combination appears to po-
tentiate the effects of the individual vitamin treatment. 
Specifically, there are abundant necrotic cells. The sur-
viving cells display morphologi cal defects characteristic 
of cell injury. 
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Introduction 
Prostatic adenocarcinoma is the most frequently di-
agnosed cancer in males and the second leading cause of 
cancer related mortality in the United States (Moon, 
1992). While a variety of treatment modalities, chemo-
therapy, radiation and biological response modifier ther-
apy have been employed in an effort to manage prostatic 
adenocarcinoma, none of these regimens has proven to 
be efficacious. These observations point to the need for 
the development of an effective regimen for treating hor-
mone-independent prostate cancer. Due to their low 
systemic toxicity, vitamins and combinations of vitamins 
have been evaluated for their antineoplastic activity. 
Taper and coworkers (Noto et al., 1989) found that 
co-administration of a Vitamin C (Vit C) and Vitamin 
K3 (Vit K3) combination (in a Vit C: Vit K3 ratio of 
100: 1) to a variety of carcinoma cell lines resulted in 
equivalent antineoplastic activity at concentrations that 
were 10-50 times lower than when either vitamin was 
administered alone. The potentiation and specificity of 
the antitumor activity were ascribed to the possible gen-
eration of peroxides followed by membrane lipid altera-
tion, DNase activation and DNA destruction by the Vit 
C and K3 combination in the catalase-deficient cancer 
cells. 
The purpose of this report is to evaluate Vit C, Vit 
K3 , and the Vit C: Vit K3 combination for their antitu-
mor activity against a human prostatic cell line (DU145) 
and to document morphological changes to subcellular 
compartments following a one hour vitamin treatment. 
Delayed cytotoxic and morphological effects of vitamins 
against DU145 cells have been evaluated and will be 
submitted elsewhere in the near future (Venugopal et al, 
in preparation). 
Materials and Methods 
Cell culture procedure 
Human prostatic carcinoma cells (DU145 cell line) 
were purchased from the American Type Culture Collec-
tion (ATCC, Rockville , MD). After reception of the 
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Table l. Anti tumor activity of vitamins with coincubation with DU145 cells. 
Coincubation Vitamins alone Vitamins Combinations Enhancement 
Period Vit C 50% Vit K3 50% Vit C 50% Vit K3 of antitumor 
cytotoxic cytotoxic cytotoxic cytotoxic activity 
dose (µM) dose (µM) dose (µM) dose (µM) (n-fold) 
5 day 2455 ± 28 12.9 ± 0.8 122 ± 15.6 1.22 ± 0.16 20 
l hour 6009 ± 8 77.2 ± 2.9 312 ± 4.0 3.12 ± 0.006 25 




50alone, where FIC is the fractional inhibitory concentration, 
CD\ 0alone and CD
8
50alone are concentrations of each drug alone producing CD50 ; CD\ 0comb is the concentration of 
drug A in combination with drug B yielding CD50 , and CD
8
50comb is the concentration of drug Bin combination with 
drug A yielding CD50 . FIC 1 hour = 0.093 and FIC 5 day = 0.145. 
frozen cells, they were thawed and centrifuged at 1000 
rpm for 10 minutes. Foilowing removal of the superna-
tant, DU145 cells were resuspended in 90% Minimum 
Essential Medium (MEM; Eagle, Gibco Labs., Grand 
Island, NY) supplemented with 10% fetal bovine serum 
(FBS; GIBCO), 50 µglml gentamicin sulfate (Sigma 
Chem. Co., St. Louis, MO) and grown in flasks until 
confluent. 
Microtiter tetrazoliwn (MTT) assay 
Corning 96-well titer plates were seeded with tumor 
cells (5. 0 x HY /well) suspended in 100 µl MEM con-
taining 10% FBS. The cells were then incubated at 37°C 
in 5 % CO2 for 24 hours. Tests solutions (8000 µM Vit 
C, 500 µM Vit K3, and 80 µM Vit K3/8 mM Vit C) 
were serially diluted with phosphat e buffered saline 
(PBS) in 12 two-fold dilutions . Each dilution was added 
to 7 wells of the titer plates and incubated at 37 ° C in 
5 % CO2 for 5 days. Following vitamin treatment and 
incubation period , host cell toxicity was assessed using 
the MTT assay in a microtiter plate reader (Alley et al., 
1988): 50 µl of 10 mM tetrazolium salt (3-[4,5-dimeth-
ylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) was 
added to each well. The microtiter plates were then in-
cubated at 37°C in 5% CO2 for 4 hours. Following in-
cubation, all but 20 µl of the supernatant was removed 
from the wells and replaced by 150 µl of dimethyl sulfo-
xide (DMSO; Sigma). Once the cells were solubilized, 
the absorbance of each well was read with a Bio 
Kinetics Reader (Model EL340; Bio-Tek Instruments, 
Winooski , VT) at 540 nm and 630 nm to eliminate back-
ground. The last six wells of the first column were used 
as MEM/tetrazolium blanks. All the wells in the last 
column of each microtiter plate Jacked cells and were 
used for the drug blanks. Sham-treated cells were used 
as the negative controls. Following linear regression, 
the line of best fit was determined and the 50 % cyto-
pathic dose (CD50) was calculated (Table 1). The frac-
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Control DU145 cells (Figures 1-6). 
Figure 1. Scanning electron micrograph of sham-treated 
cells reveal the typical spherical shape of the cells. Bar 
= 10 µm. 
Figure 2 . Scanning electron micrograph of sham-treated 
cells illustrating a flat cell. Open arrow: contacting 
filopodia . Bar = 5 µm. 
Figure 3 . Transmission electron micrograph of a sham-
treated cell . Note the lobed nucleus and large glycogen 
deposits (*), lysosomes /residual bodies near the nucleus 
and the abundant mitochondria. Note a adjacent cell with 
a characteristic intracellular lumen (i) . Bar = 5 µm . 
Figure 4. Transmission electron micrograph of the cy-
toplasm where TRS (arrows) are depicted among other 
organelles. Arrowhead: mitochondria . Bar = 1 µm. 
Figure 5. Enlarged nucleu s of DU145 cell showing 2 
nucleolar bodies , each containing 2-4 fibrillar centers 
(curved arrow) . Bar = 1 µm. 
Figure 6. Transmission electron micrograph of enlarged 
perikaryal annulate lamellae. a: annulate lamellae; n : 
nucleus ; arrowhead : mitochondria . Bar = 200 nm. 
tional inhibitory concentration index (FIC; Siihnel, 1990) 
was employed to evaluate synergism, additivism, and an-
tagonism. Using the same concentration of Vit C, Vit 
K3 and the combination of the two vitamins, a similar 
MTT assay was evaluated after a 1 hour treatment 
(Table 1). 
Treatments and preparation for microscopy 
Two 12-mm circular glass coverslips or two 100-
mesh gold grids were placed in a 35 mm Perri dish. 
Synergi stic antitumor activity of vitamin C - vitamin K3 combinations 
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Each Petri dish was seeded with 1.0 x 106 DU145 cells 
suspended in MEM containing 10% FBS. After 24 hour 
incubation at 37°C in 5% CO2, MEM was removed and 
the cells were washed once with 3 ml of PBS (pH 7 .2). 
The cells were then overlaid with 2 ml of MEM contain-
ing either Vit C (6007 µM), Vit K3 (77.2 µM), or Vit 
C:Vit K3 (312 µM : 3.1 µM) combination. These 
values corresponded to the CD50 doses determined by 
MTT analysis . MEM-treated DU145 cells were used as 
the negative control. After 1 hour of incubation at 37 °C 
and 5 % CO2, the vitamins were removed from the cells 
and the cells were rapidly washed twice with 3 ml of 
PBS. Glass coverslips and grids covered by DU145 
cells were transferred to another Petri dish for scanning 
electron microscopy (SEM). The DU145 cells that 
adhered to the Petri dish following vitamin treatment 
were harvested by soaking them free from the mono-
layer with no-zyme (JRH Bioscience , Lenexa, KS), cen-
trifuged at 1000 rpm for 10 minutes and then prepared 
for transmission electron microscopy (TEM). 
Scanning electron microscopy (SEM) preparations 
DU145 cells on the glass coverslips and grids were 
covered with 3.2 % buffered glutaraldehyde solution (0.1 
M Na cacodylate; pH 7.32) for 10 min at 4°C (Allen, 
1983; Glauert, 1984; Prince et al., 1993). After two 
rapid washes with sucrose-cacodylate buffered solution 
(SC), the preparations were postfixed for 30 minutes at 
room temperature in 1 % aqueous solution of osmium 
tetroxide-ruthenium tetroxide (1:1). The rationale in 
using ruthenium tetroxide (RuO.J with osmium tetroxide 
(OsO4) is to allow the fixation to penetrate rapidly into 
cell structures and to compound its fine fixative quality 
with that of osmium tetroxide (Gaylarde and Sarkany, 
1968; Gilloteaux and Naud , 1979; Hayat, 1970). Fol-
lowing fixation, the samples were then washed four 
times with the SC solution and dehydrated through a 
graded series of ethanol. Critical-point drying was 
performed in a Polaron E 3000 apparatus (Polaron/Bio-
rad, Cambridge , MA) using liquid CO2 as transitional 
fluid. After gluing each cover slip on an aluminum 
holder with conductive silver paint (high purity silver 
paint; SPI, West Chester, PA) or each gold grid with 
double-side adhesive tape (Avery Dennison, Azusa, CA) 
and paint; all the SEM samples were sputter-coated with 
a Hummer VI-A (Anatech Ltd., Alexandria, VA) with 
a 20 nm-thick gold layer before observation with a 
JEOL JSM-35C SEM operated at an accelerating voltage 
of 15 kV. 
Transmission electron microscopy (TEM) 
preparations 
The supernatant was removed and replaced by the 
same buffered glutaraldehyde solution as that used for 
the SEM preparations except that the fixation was car-
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Vitamin C treated DU145 cells (Figures 7-13). 
Figures 7 and 8. Scanning electron micrographs of 
DU145 cells with extended lamellipodia (Fig. 7), reticu-
lated (r) filopodial field and extensive blebbing (Fig. 8). 
Bars = 10 µm. 
Figure 9. This transmission electron micrograph shows 
cytoplasmic vacuolization and residual bodies randomly 
scattered throughout the cytoplasm of several cells. *: 
glycogen deposits. Bar = 5 µm. 
Figure 10. Enlargement of peripheral cytoplasmic re-
gion demonstrating reticulated microvillar-like anasto-
moses, membranous blebs (b) perikaryal residual bodies 
(arrow) and mitochondria (arrowhead). Open arrow: 
onion-like body . Bar = 1 µm . 
Figure 11. Enlargement of the cytoplasmic glycogen 
deposits(*) loosely surrounded by a membranous (lyso-
sornal-like) structure (arrows). Extracted fatty deposits 
(f) are also present. Bar = 1 µm. 
Figure 12. An example of condensed nucleolus showing 
nucleolar chromatin condensation (curved arrow). Bar 
= 1 µm. 
Figure 13. Transmission electron micrograph ofperinu-
clear cytoplasm with anastomosed and fragmented TRS 
(open arrow) and condensed nuclear envelope. Bar = 
200 nm. 
ried out at room temperature for 1 hour. After two 
rapid rinses in SC solution, postfixation was done for 1 
hour at room temperature with 1 % aqueous osmium te-
troxide solution. The pelleted cells were washed in the 
SC solution before dehydration in graded ethanol, and 
processed in PolyBed epoxy resin (Polysciences, War-
rington, PA) . One-micrometer thick sections were 
stained by toluidine blue and selected areas were col-
lected as ultrathin sections on 75-and 100-mesh hexago-
nal copper grids (SPI). The sections were contrasted by 
uranyl acetate and lead citrate and were examined in a 
JEOL lO0S transmission electron microscope operated 
at an accelerating voltage of 80 kV. 
Results 
A MTT-microtiter tetrazolium assay has been 
employed to determine if Vit C and Vit K3 exhibit syn-
ergistic antitumor activity against prostatic carcinoma. 
When the test agents are incubated with DU145 cells for 
l hour, the CD50 of Vit C alone is 6009 µM and the 
Synergistic antitumor activity of vitamin C - vitamin K3 combination s 
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CD50 of Vit K3 alone is 77 .2 µM. When Vit C is com-
bined with Vit K3 to produce a Vit C/Vit K3 ratio of 
100: 1, the ratio of CD50 for the two vitamins is 312: 
3.12. These results demonstrate that when Vit C is 
combined with Vit K3, the CD50 of Vit C decreases 
from 6009 µM to 312 µM (a 20-fold decrease), while 
the CD 50 of Vit K3 decreases from 77 .2 µM to 3.12 µM 
(a 25-fold decrease). The FIC index (Siihnel, 1990) has 
been employed to evaluate synergism, additivism or 
antagonism . A FIC < 1.0 indicates the combination is 
synergistic, while a FIC > 1.0 indicates the combina-
tion is antagonistic. A FIC :::: 1.0 indicates the combi-
nation is additive or indifferent. Employing these crite-
ria, Vit C and Vit K3 exhibit a marked synergism (FIC 
= 0.093) when they are administered at an Vit C/Vit K3 
ratio of 100: 1. 
For ease of comparison, scanning and transmission 
electron micrographs are presented together: control 
DU145 cells (Figs. 1-6), Vit C-treated DU 145 cells 
(Figs. 7-13), Vit Krtreated DU145 cells (Figs . 14-20) 
and Vit C/Vit K3-treated cells (Figs. 21-29). 
Scanning electron microscopy 
Untreated (control) DU145 cells (Figs. 1 and 2): 
Untreated DU145 cells are typically spherical and have 
diameters ranging from 12 to 17 µm (Fig. 1). These 
cells show a narrow rim of lamellar cytoplasm from 
which discrete surface specializations in the form of ra-
dial lamellipodia and/or filopodia originate . While the 
former can barely be detected at low magnifications of 
SEM, the latter can be seen to originate from one sector 
of the cell. The lamellipodia can protrude up to 2 µm 
outside the main cell surface, while the filopodia can 
measure up to 15 µmin length and 0 .2 µmin diameter. 
Control cells show a tendency to overlap and aggregate 
in groups of up to 13. These cells, or colonies, appear 
to be flat when they are confluent and can attain a diam-
eter of 30 µm in their long dimension and 20 to 30 µm 
in their shorter dimension (Fig . 2) . Due to the flattened 
appearance of confluent cells, it is difficult to appreciate 
their width . Under such conditions , round cells can 
sometimes be detected overlapping the flat cells . During 
cell aggregation, adjacent cells display complementary 
interlocking three dimensional structures (same size and 
length) and have focal contact with very short filopodia 
(Fig. 2). 
Vitamin C-treated DU145 cells (Figs. 7 and 8): 
Vit C-treated DU145 cells are pleomorphic . Vit C-treat-
ed cells also have a tendency to form colonies like the 
untreated DU145 cells. Contacts between adjacent cells 
are similar to control cells. However, profound mor-
phological alterations can be detected in the form of 
membrane extensions or radial appendages, i.e. , lamel-
lipodia - and filopodia -like extensions as well as irregular 
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Vitamin K3- treated DU145 cells (Figures 14-20). 
Figures 14 and 15. Vitamin Krtreated cells with pre-
dominant membranous blebs and thick curly pseudopodia 
which depicts zeiosis. This suggests Krinduced altera-
tions in the cytoskeleton of the cell. Bars = 25 µm 
(Fig. 14) and 10 µm (Fig. 15). 
Figure 16. Closer examination of a residual body indi-
cates that it has a whorled appearance and originates 
from damaged mitochondria (arrow). Bar = 1 µm. 
Figures 17 and 19. Intense cytoplasmic vacuolization 
and residual bodies are randomly scattered throughout 
the cytoplasm. In contrast to Vit C treatment, the glyco-
gen deposits (*) appear unaffected by the vitamin treat-
ment. The cells display long cytoplasmic digitations. 
Notice the enlarged nucleolu s. Bars = 10 µm. 
Figure 18. Scanning electron micrograph of a DU145 
Vit K3-treated cell showing many irregular blisters and 
entangled filopodia . Dilated membranous blebs surround 
the main cell body thereby giving it a petal-like appear-
ance. Bar = 10 µm . 
Figure 20. Enlarged view of a dense body originating 
from a mitochondrium (arrow) . Apparent curved cis-
temae can be observed adjacent to the dense body. The 
morphology of these cistemae resembles TRS. Bar = 
200 nm. 
and unequal projections from the cell surface. When la-
mellipodia are present , they can reach up to 4 to 5 µm 
in length . In some part s of the cell surface , lamellipodia 
can be observed as ruffle s with filopodia arising random-
ly from the upper ridge s of the lamellipodia (Figs. 7 and 
8). The filopodia are typically tenuous and can show a 
reticulated aspect (Fig . 8) which is confirmed by TEM 
(Fig . 10) . These filopodia can be as large as 10 µm in 
length and 0 .2 µm in diameter. Vit C-treated cells dis-
play cell shapes varying from almost spherical to almost 
flattened and , in some cases, even crenate in appear-
ance . Frequently , the nuclear region protrudes outward 
from the cell surface . These cells are sometimes dough-
nut shaped (similar to Vit Krtreated cells shown in Fig. 
22) . 
Vitamin Krtreated DU145 cells (Figs. 14, 15 and 
18): Vit K3-treated cells show a large lamellar cyto-
plasm when they are confluent. When ovoid, these 
cells, like the Vit C-treated cells, show a tendency to 
aggregate . These cells can also be oblong in appearance 
and possess surface modifications like lamellipodia, 
pseudopodia, filopodia and blebs of irregular size and 
Synergistic antitumor activity of vitamin C - vitamin K3 combinations 
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Some of these extensions are similar to those observed 
in Vit C (compare Fig. 15 with Figs. 7 and 8). In 
addition, many cells show numerous large blebs budding 
from the same region of the cell as surface modifications 
and results in further disorganization of the outline of 
the cells. Blebs can measure up to 3 µm in diameter. 
In addition, long or wavy pseudopodia can also be 
detected (Figs. 14 and 15). Filopodia are more than 10 
µmin length and typically 0.2-0.3 µmin diameter. Iso-
lated cells exhibit irregular pseudopodia! and filopodial 
processes and attempt to contact other cells via such 
processes (Fig. 14). When cells do not make contacts 
with neighboring cells, they form wide and radial lamel-
lar cytoplasmic arms of about 5 µm in width giving the 
cell a rosette appearance. Alternatively, these cell 
extensions could be indicative of zeiosis (Fig. 18). It is 
not unusual to also observe many doughnut-shaped cells 
and necrotic cells in a field of view. 
Vitamin C/Vitamin Krtreated DU145 cells (Figs. 
21, 22 and 29): These cells appear round to ovoid. Vit 
C/Vit K3-treated cells are attached to the substrate by 
means of a basal array of narrow and radiating lamellar 
cytoplasmic arms arising from the basal portion of each 
cell. Long filopodia can be seen to arise from these 
arms (Figs. 21 and 22). These cells form large clusters. 
Surface modifications like blisters, irregular lamellipo-
dia, and filopodia cover the entire surface of these cells. 
Necrotic cells can also be observed in a field of view. 
Such necrotic cells exhibit either cell remnants from 
which nuclei have been extruded (Fig. 22) or a severed 
nuclear region which can still be detected among cyto-
plasmic fragments (Fig. 29). 
Transmission electron microscopy 
Control DU145 cells (Figs. 3-6): At low magnifi-
cations, DU145 cells display a round to polygonal pro-
file and are coated with short (0.5 µm), microvilli-like 
digitations of equal height. Cells which exhibit polygo-
nal profiles contact each other by intermingling their mi-
crovillar extensions. In some instances, one can detect 
small to large intracellular lumens delineated by micro-
villar-like surfaces (Fig. 3) . 
The nucleus is generally multi-lobed and often 
shows deep cytoplasmic indentations. Many nucleoli 
contain multiple fibrillar centers, i.e., nucleolar organ-
izers regions (NORs). This excess in the number of 
NORs is characteristic of tumor cells (Fig. 5; 
Schwarzacher and Wachtler, 1993). Abundant electron 
dense residual bodies are present in the perinuclear 
regions. These residual bodies are located in either the 
major concavity of the perikaryons or in a concentric, 
non-peripheral distribution (Figs. 3 and 6). 
Mitochondria occupy a large volume of each cell, 
show a pale matrix and are dilated with diameters as 
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Vitamin C/Kr treated cells (Figures 21-29). 
Figure 21. Illustration of elongated cells with many 
surface blisters and blebs. Lamellipodia ( curved arrow) 
display clusters of excrescences. Bar = 10 µm. 
Figure 22. An example of a doughnut shaped cell with 
numerous surface extensions and bulging cytoplasm (b). 
Bar= 10 µm. 
Figures 23 and 24. Illustration of Vit C/Krtreated 
demonstrating aggregates of swollen mitochondria with 
defective matrix (small arrow). f: fat; arrowhead: RER; 
large arrows: residual body. Bars = 1 µm. 
Figure 25. Transmission electron micrograph of nu-
cleolus with many fibrillar centers. Curved arrow: nu-
cleolar-associated chromatin . Bar = 1 µm. 
Figure 26. Illustration of a vacuolated cell with con-
densed nucleolus. Notice an example of glycogenic de-
posit surrounding an extracted fatty deposit (*). Cyto-
plasmic extrusions typical of zeiosis (arrow) can also be 
seen. Bar = 10 µm. 
large as 0 .5 µm (Figs. 3, 4 and 6) . Large cytoplasmic 
deposits of glycogen can be detected in many DU145 
cells. They are often ectoplasmic and can occupy as 
much as half of the cell profile (Fig. 3). 
RER and associated polysomes are easily detectable 
and dispersed throughout the cell cytosol. These cells 
contain abundant SER, some of which resembles tubulo-
reticular structures (TRS). These TRS are often detect-
ed as elongated (1 to 3.5 µm long) meandering or sinu-
ous structures in the peripheral cytoplasm (Fig. 4). A 
small number of minute pale to electron-lucent spaces, 
which are lipid-containing vacuoles (Fig . 3), are also 
present. These fatty deposits are also observed in 
treated cells (Figs. 11 and 24). Close examination of 
the DU145 control cells allowed us to often observe 
annulate lamellae in their perikaryons (Fig. 6). These 
cellular substructures are often detected in tumor cells 
(Ghadially, 1988). 
Vitamin C-treated DU145 cells (Figs. 9, 10, 11, 
12 and 13): As a result of Vit C treatment, the cells 
lose their spherical shape and acquire a more elongated 
profile with irregularly-shaped, branching extensions and 
intricate unequal surface folds . Arising from these ex-
tensions, one can note more delicate microvillar-like 
structures (Fig. 9) and membranous blebs containing 
foam-like structures which are outlined by a membra-
nous boundary (Fig. 10). These extensions appear in an 
anastomosing and reticulated pattern (Fig. 10). 
Synergistic antitu . . mor activity of vit . . amm C - vita . lilill K C b. 3 om mations 
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Vit C-treated cells show nuclei with more rounded 
profiles than control DU145 cells. Vacuolated and swol-
len cells possess eccentric nuclei and display characteris-
tics of cell injury indicating an early step of cell degen-
eration (Fig. 9). The nuclear indentations appear to be 
fewer and are less deep than in control cells. A striking 
feature is the nucleolus which is enlarged, often single, 
and has a moth-eaten aspect among finely dispers ed het-
erochromatin. Fine fibrillar centers can be detected 
among more electron dense material which probably 
consists of the dense fibrillar component. There is an 
apparent condensation of perinucleolar chromatin within 
sections of the nucleolar bodies (Fig . 12). The overall 
electron density of the nucleolar components makes it 
168 
Figure 27 . An example of a cell con-
taining an extremely large lysosomal 
vacuole containing heterogenous mem-
branes and clumped material. Notice 
the intact peripheral glycogen deposits 
(*). Bar = 5 µm. 
Figure 28 . Illustration of a necrotic 
cell in the process of expelling cyto-
plasmic buddings. Notice the neighbor-
ing cell whose cytoplasm is rich in 
swollen mitochondria (long arrow as 
shown in Figure 24). Arrows: budding 
excrescences. Bar = 10 µm. 
Figure 29 . Scanning electron micro-
graph of a necro tic cell with segregated 
nuclear bulging (n) which is surrounded 
by cytoplasmic debris. Bar = 10 µm. 
difficult to distingui sh the granular component. 
Although the granular component is present, it is dis-
persed among the aforementioned nucleolar substruc-
tures. The inner nuclear membrane shows a thick layer 
of heterochromatin (Fig. 13) when compared to the 
nuclei of control cells and Vit K3-treated cells. 
Following treatment, many cells display intense 
cytoplasmic vacuolization and residual bodies are ran-
domly scattered among the cytoplasmic organelles as 
well as in the perikaryon (Figs. 9 and 10). Among the 
residual bodies, one observes condensed mitochondrial 
matrices and altered mitochondria which suggest a mito-
chondrial origin for these residual bodies. Other dense 
bodies appear in the form of onion-like bodies . 
Synergistic antitumor activity of vitamin C - vitamin K3 combinations 
Cytoplasmic vacuolization appears within the glyco-
gen patches and in the vicinity of lipid droplets (Fig. 
11). Lipid droplets detected as empty spaces among the 
glycogenic stores are likely to be related to the proce-
dures of fixation and dehydration (Glauert, 1984; Stein 
and Stein, 1971) and cytoplasmic vacuoles in the area of 
the glycogenic patches contain an electron lucent area 
(vacuole) that is circumscribed by a SER-like membra-
nous structure which suggests a possible lysosomal gene-
sis (Fig. 11). In addition, the perinuclear regions con-
tain networks of anastomosing or fragmented TRS (Fig. 
13). As in the control cells, the overall cytoplasm con-
tains abundant fine electron dense granules which are 
probably ribosomes. Alternatively, many of these gran-
ules could represent ribosomes which have degranulated 
from the RER. 
Vitamin K3-treated DU145 cells (Figs. 16, 17, 19 
and 20): Following Vit K3 treatment, most cells appear 
ovoid or elongated and display smooth surfaces which 
are often free of microvillar-like surface profiles (Figs. 
17 and 19). Most remaining cellular extensions are long 
and scattered along the cell surface. These morphologi-
cal aspects confirm the SEM observations (Figs. 14, 15 
and 18). An example of zeiosis (blebs containing, e.g., 
organelles and glycogenic stores) is depicted in Figure 
17. Cells show membranous blebs and round ruffles 
which are several micrometers in diameter (Figs. 17 and 
19 similar to what is observed in Figs. 26 and 27). At 
low magnification, cells appear to aggregate and large 
cells tend to surround the smaller ones within their ex-
tensions (Fig. 19). In addition, membranes exhibit nu-
merous blebs which are delineated by a unit membrane. 
The large blebs or dilated ruffles do not appear to con-
tain organelles, but do contain glycogen laden vacuoles 
which are surrounded by an electron dense cytoplasmic 
rim not thicker than 0.2 µm. 
The nucleus is discretely lobed and the nucleoli of 
these Vit Krtreated cells are significantly enlarged and 
can appear round or branching . Nucleolar bodies are 
enlarged when compared to those of untreated cells and 
range from 2 µm to 6 µmin diameter . There is an ap-
parent condensation of the nucleolar chromatin within 
sections of the nucleolar bodies (Fig. 12). The hetero-
chromatin is dispersed in small patches throughout the 
nucleoplasm and the nucleoli contain several fibrillar 
centers. 
In addition to glycogen patches , the cytoplasm of 
Vit Krtreated cells appears extensively vacuolated in the 
elongated cells and slightly vacuolated in the rounded 
cells. These rounded cells also possess a large number 
of dense bodies in their perikaryons (Figs. 17 and 19). 
At higher magnification, these electron dense structures 
appear to be vacuolated and non-vacuolated onion-like 
bodies. Upon closer examination of the same Vit K3-
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treated DU 145 cells, one can determine that most, if not 
all, of these dense bodies originate from mitochondrial 
alterations (Figs. 16 and 20). Enlarged and altered 
mitochondria can be detected among the dense bodies. 
These mitochondria have a pale matrix and disorganized 
cristae (Fig. 20). SER and dense bodies are seen in the 
cytoplasm. In addition, many small cistemae form a 
vacuolated network among these dense bodies. These 
cistemae are usually curved and measure about 45 to 
300 nm in diameter or width and appear as sectioned 
TRS (Fig. 20). These cistemae are extensively devel-
oped in the elongated cells which surround the smaller 
cells. 
Vitamin C/Vitamin K3-treated DU145 cells (Figs. 
23-28): Vit C/Vit K3-treated cells appear round to 
ovoid and possess a high nuclear to cytoplasmic ratio. 
One reason for this type of change is that these cells ap-
pear to extrude large portions of their cytoplasm into 
protruding blebs. The outline of intact cells is clearly 
surrounded by numerous thin and thick irregular micro-
villi as well as by short ruffles or blebs of the cell sur-
face (Figs. 23, 27 and 28) . The cells that contact each 
other show more electron density and exhibit a more 
"intact" appearance than those which have not made 
such contact. These scattered cells appear to undergo 
necrosis associated with the aforementioned intense 
zeiotic blebbing of cytosolic fragments (Figs. 26 and 
28). As was the case in SEM, it is quite common to 
find necrotic cells in TEM also (Figs. 26 and 28). 
Nuclei of Vit C/Vit Krtreated cells are lobed; they 
are larger and less condensed than the Vit C or Vit Kr 
treated cells (Fig. 26). If the nucleoli are branched, 
then they occupy a large volume of the nucleoplasm 
(Figs. 25 and 28). Enlarged nucleoli show loose inter-
stices with incomplete rings of dense fibrillar material. 
It is difficult to differentiate the nucleolar-associated 
chromatin from the nucleolar material proper (Fig. 25). 
The cytosol of Vit C/Vit Krtreated cells is very granu-
lar with many of these granules corresponding to the 
size of ribosomes. The RER is scanty and only present 
in the form of minute membranous fragments adjacent 
to the damaged mitochondria (Figs. 23 and 24). As a 
result of degranulation of the RER, large quantities of 
ribosomes are dispersed between all the organelles of the 
cell (Fig. 24). The cytoplasm is moderately vacuolated 
and contains small (1-1.5 µm) to extremely large (4.0-
6.5 µm) heterogenous vacuoles which can be in close 
contact with the nuclear envelope (Figs. 26 and 27). 
Lipid-containing vacuoles are not more than 1 µm in di-
ameter and are electron lucent. 
In some of the cells, the mitochondria display their 
orthodox substructure and are surrounded by networks 
of typical RER. However, most mitochondria are 
dilated, possess damaged cristae and contain a hetero-
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geneous matrix (Figs. 24 and 28). Some of the 
apparently intact cells contain aggregates of typical 
mitochondria and dilated mitochondria (Fig. 24) which 
may occupy a large volume of the cytoplasm. All of 
these features may contribute to the vacuolated aspect of 
the cytoplasm. 
However, as was the case in the Vit K3-treated 
cells, all the cells observed in our preparation contained 
numerous dense residual bodies originating from the mi-
tochondria. Some residual bodies can reach up to 3 µ,m 
in diameter. In addition, large (2 µ,m) lamellated onion-
like bodies can be seen. Enormous heterogenous inclu-
sions (up to 15 µm in diameter) can be found in some 
large cells. These inclusions represent large autophago-
somes or heterophagosomes which can result from can-
nibalization of necrotic cells. Figure 26 demonstrates 
this type of event and also shows that large glycogenic 
reserve patches are still present in the cytoplasm follow-
ing Vit C/Vit K3 treatment. 
Discussion 
The DU145 cell line is a promising in vitro model 
for human prostatic carcinoma because it can be main-
tained in long term culture and its growth is hormone-
independent (Chakraborty and Von Stein, 1986). 
DU145 cells in culture show rounded appearance espe-
cially when they are isolated and/or when ready for mi-
totic activity. It has been observed that DU145 and PC-
3, both human prostatic adenocarcinoma cell lines , dis-
play characteristic bimorphism and appear phenotypical-
ly as rounded or flattened cells (Carruba et al., 1989). 
Besides being a characteristic feature of germ cells, an-
nulate lamellae are also found or induced in tumor cells 
(Ghadially 1988; Kessel, 1968, 1973, 1983) and are ob-
served in untreated DU145 cells. 
The results of in vitro studies demonstrate that Vit 
C exhibits a selective toxicity towards malignant melano-
ma cells (Bram et al., 1980), human leukemia cells 
(Park et al., 1980), neuroblastoma cells (Prasad et al., 
1979), and tumor ascites cells (Liotti et al. , 1984). The 
mechanism(s) responsible for the antitumor activity of 
Vit C are obscure, but may be related to the ability of 
Vit C to inhibit macromolecular synthesis to induce 
DNA strand breaks and cross-links (Noto et al., 1989; 
Pavelic et al., 1989). 
Ultrastructural studies (Lupulescu, 1992) of Vit C-
treated basal cell and squamous cell carcinoma cells re-
vealed advanced cytolysis, cell disorganization, mem-
brane disruption, mitochondrial alterations, and nu-
clear/nucleolar reduction as well as increased phagolyso-
some formation and collagen synthesis. Moreover, the 
TRS complexes (Ghadially, 1988; Orenstein, 1992), ob-
served in the untreated cells, are often fragmented fol-
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lowing this treatment. These results suggest that the an-
titumor activity of Vit C may be due to increased cytoly-
tic and autophagic activity with vacuolated degeneration 
and the subsequent disruption of cellular membranes . 
Vit K3 (menadione , 2-methyl-1,4 -naphthoquinone) is a 
synthetic derivative of Vit K1 that exhibits broad spec-
trum anticancer activity against human cancer cell lines 
and against human tumor explants which are refractory 
to other types of chemotherapy (Chlebowski et al., 
1985; Nutter et al., 1991; Wu et al. , 1993). Adminis-
tration of Vit K3 is known to induce a variety of effects 
including: increased consumption of molecular oxygen 
and generation of superoxide, depletion of glutathione 
(GSH), oxidation of protein sulfhydryl groups in cyto-
skeletal proteins, alterations in pyridine nucleotide pools, 
decreases in mitochondrial and cellular ATP pools, ef-
fects on calcium homeostasis, and single-stranded DNA 
breaks (Gant et al., 1988; Mirabelli et al., 1989; 
Stubberfield and Cohen, 1989). 
Ultrastructural studies (Bellomo et al., 1990; 
Malomi et al . , 1991) of Vit Krtreated hepatocytes and 
other human cell lines demonstrated that intracellular 
sulfhydryl groups can be oxidized by Vit K3 which can 
lead to the disruption of the cell cytoskeleton, nuclear 
architecture, plasma membrane and exoplasmic region of 
the cytoplasm. TRS appear to be fragmented as a result 
of this treatment. Vit K3-treatment apparently causes a 
decrease in the cysteine moieties required during the as-
sembly and regulation of cytoskeleton and hence contrib-
ute to the oxidative stress affecting the cells. It is be-
lieved that one or more of these effects is responsible for 
the antitumor activity of Vit K3 . Vit C/Vit K3 combina-
tions are known to exhibit antitumor activity. Previous 
work by Taper and his associates demonstrates that 
when Vit C and Vit K3 are combined in a ratio of 
100: 1, the combination exhibits potentiated in vitro anti-
tumor activity against MCF- 7 (breast carcinoma), KB 
(oral epidermoid carcinoma), and ANrCA (endometrial 
adenocarcinoma) cell lines as well as in vivo antitumor 
activity in hepatoma-bearing mice (De Loecker et al., 
1993; Noto et al., 1989). Tumor specific antitumor ac-
tivity was achieved with exposure times as short as 1 
hour at doses which were 10-50 times lower than when 
either vitamin was administered alone. Additional stud-
ies using hepatoma-bearing mice as a model have shown 
that the Vit C/Vit K3 combination is an effective chemo-
sensitizer and radiosensitizer (Taper et al., 1987; Taper 
and Roberfroid, 1992). Autopsies of hepatoma-bearing 
mice have revealed that the Vit C/Vit K3 combination 
induces little or no major organ pathology when it is 
administered alone and no additional systemic and major 
organ pathology when it is administered in conjunction 
with radiosensitizers or chemosensitizers (Taper and 
Roberfroid, 1992). The potentiation and specificity of 
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the antitumor activity were ascribed to the possible gen-
eration of peroxides followed by membrane lipid altera-
tion, DNase activation and DNA destruction by the Vit 
C and K3 combination in the catalase-deficient cancer 
cells (Noto et al., 1989; Taper et al., 1987). 
In the current study, an MTT assay was employed 
to demonstrate that the Vit C-Vit K3 combinations with 
Vit C: Vit K3 ratios of 100: 1 exhibit synergistic anti-
tumor activity against a human prostatic carcinoma cell 
line, DU145 . A 5 day vitamin treatment of the DU145 
cells resulted in CD50 values of 2,455 µM for Vit C, 
12.9 µM for Vit K3 and 122 µM ; 1.22 µM for the Vit 
C/ Vit K3 combination. These results represent a 20-
fold decrease of the CD50 of Vit C and a 10-fold de-
crease in the CD50 of the Vit K3. The MTT assay has 
also been employed to evaluate the antitumor activity of 
Vit C, Vit K3 and the Vit C/Vit K3 following a 1 hour 
treatment. Following a 1 hour exposure of the DU145 
cells to the vitamins, the CD50 values of Vit C, Vit K3 
and the Vit C/Vit K3 combination are 6009 µM, 77.2 
µM and 312 µM/3.12 µM respectively . These values 
correspond to a 20-fold decrease in the CD50 value of 
Vit C, a 25-fold decrease in the CD50 value of Vit K3. 
Recently, similar results have been obtained for two 
bladder carcinoma cell lines, RT4 and T24 . Exposure 
of two of the three cell lines (DU145 and T24) to 
varying doses of exogenous catalase prior to vitamin 
treatment abrogated the antitumor activity of the 
vitamins. The amount of catalase required to destroy 
the antitumor activity of Vit K3 alone was greater than 
or equal to the amount of catalase required to destroy 
the antitumor activity of the Vit C/Vit K3 combination. 
The results of these studies demonstrated that while 
hydrogen peroxide is involved in the mechanism of 
action of these vitamins, the enhanced antitumor activity 
of the Vit Cl Vit K3 combination was not simply due to 
the increased production of hydrogen peroxide 
(Venugopal et al., 1995a,b, submitted). 
The close agreement between the CD50 values of the 
Vit C/Vit K3 combination for the 1 hour vitamin expo-
sure (312 µMl 3.12 µM) and the CD50 values of the Vit 
C/Vit K3 combination for the 5 day exposure (122 µM l 
1.22 µM) suggested that a 1 hour treatment was almost 
as effective as a continuous 5 day vitamin treatment. 
These results suggest that some of the events responsible 
for triggering tumor cell death occurred during the first 
hour of vitamin treatment and may be caused by oxida-
tive stress and cell injury (Martin, 1993). As an initial 
step in elucidating these processes, SEM and TEM have 
been employed to examine vitamin-induced changes in 
DU145 ultrastructure following a 1 hour exposure to the 
vitamins. 
Treatment of DU145 cells by Vit C/Vit K3 combi-
nation exacerbates the individual effects of either vita-
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ruins by altering nucleoli and key cytoplasmic organelles 
[i.e., mitochondria; Fig. 24; lysosome, Figs. 23 and 27; 
Allen (1987)], stress filaments (i.e., superficial cytoskel-
eton Figs. 21, 26 and 29), and other cytoskeletal struc-
tures (i.e., intermediate filaments and/or rnicrotubules; 
Fig. 22). In addition, degranulation of RER is char-
acteristic of an early cell damage (Reid et al . , 1970). 
A second type of cell death begins to appear after 
24 hours and reaches its peak 4-5 days following vitamin 
treatment. As an initial step in elucidating these proc-
esses, SEM and TEM have also been employed to exam-
ine vitamin-induced changes in DU 145 ultrastructure fol-
lowing a 1 hour exposure to the vitamins and a subse-
quent 24 hour incubation in culture medium (in prepara-
tion). Additional experiments designed to evaluate 
cellular catalase and superoxide dismutase levels as well 
as the effects of these vitamins on cellular levels of 
thiols are in progress . 
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Discussion with Reviewers 
W.H. Wilborn: You have described an interesting and 
important effect of a vitamin C-vitamin K3 combination 
on DU145 cells, a human prostatic cancer cell line. 
Why have you not quantified your findings for the vita-
mins alone and for the combination of vitamins? The 
means are readily available and the data would add sig-
nificance to your study? 
Authors: The quantitative analysis of each vitamin and 
their combination in terms of cytotoxicity was presented 
at the National Meeting of the Basic Urologic Research 
held in San Francisco (May 1994) and has been submit-
ted to another scientific journal. 
A. Reith: On what ground did you limit your SEM and 
TEM observations to a "one hour" incubation with 
combined vitamins? 
Authors: The "one hour" incubation was chosen as 
model for a potential and practical urologic treatment. 
Our experimental results have shown that a "one hour" 
treatment is as effective as a longer duration treatment 
(up to 5 days). This longer treatment does not improve 
significantly the cytotoxic effect found after "one hour" 
treatment (see Table 1 and Discussion) . 
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A. Reith : To conclude that your observations suggest 
an effect of the vitamins on the cytoskeleton of the 
DU145 cells takes a solid stretch of the imagination 
since no cytoskeletal element is demonstrated in any of 
your micrographs! Even the evidence presented for cy-
toplasmic blebs is rather weak. Still, it is on these blebs 
that you based a suggestion for a cytoskeletal effect 
(legend of Figs. 14 and 15). Please clarify. 
Authors: We agree with the comments of the reviewer 
that we have only indirect evidences for the cytoskeletal 
damages induced by the vitamins. These include charac-
teristic morphological changes viewed with the SEM: (a) 
cell surface and superficial, cytoplasmic morphology are 
directed and/or influenced by the architectural arrange-
ment of stress (actin and associated proteins) filament 
complexes (blebs); (b) the cytoskeletal intermediate fila-
ment damages can affect the overall shape of the cell, 
the integrity and the positioning of the nucleus and its 
adjacent area. Additional information has been provided 
with the TEM. These observations support the filopodi-
al changes due to the absence or defect of axial suppor-
tive structures. In most cases, the filopodia appear 
short. When elongated, they are irregularly-shaped and 
entangled as if a network was created by the lack of or-
ganized stress filaments and cytoskeleton. Mitochondrial 
damage can lead to the depletion of cell energy charge 
[Atkinson DE (1968) The energy charge of the adenylate 
pool as a regulatory parameter. Interactions with feed-
back modifiers . Biochemistry 7, 4030-4040) and this in 
turn contributes to the membrane leaks and defects . In 
addition, it can prevent polymerization and maintenance 
of actin and of other important cytoskeletal structures. 
We agree that we have not reported any image about the 
microtubules in this report but our morphological studies 
are in progress and we plan to report about this in 
future. 

